Cultivation Capital’s Life Sciences Fund II invests in early-stage life sciences companies, primarily in the therapeutics, diagnostics, research tools and reagents, medical devices, and healthcare information technology verticals.
Our sweet spot is providing post-seed/pre-Series A stage companies the capital they need to rapidly scale their businesses. Our initial investment ranges from $250,000 – $1,000,000, with opportunities for follow-on investment.
Our partners are seasoned entrepreneurs turned investors, who know what it takes to grow and successfully exit a life sciences business. Drawing upon their expertise, we actively support our portfolio companies, many times serving as a lead investor and board member.